Rome’s falling artefacts, solo travel and more in the latest issue of Business Destinations
Feb 22, 2018 12:07 pm UTC| Business
LONDON, Feb. 22, 2018 -- Rome still continues to be one of the world’s most dazzling destinations. But with some of its artefacts being around 2,000 years old, it faces huge challenges maintaining this position. The...
Lincoln Military Housing Brings On Jill Dorflinger as Regional Vice President
Feb 22, 2018 12:05 pm UTC| Business
Oceanside, CA, Feb. 22, 2018 -- Lincoln Military Housing (LMH) today announced that Jil Dorflinger has joined the company as Regional Vice President of the Southwest Marines Region. In her role, Mrs. Dorflinger will...
Feb 22, 2018 12:03 pm UTC| Business
NEW YORK, Feb. 22, 2018 -- Edgar Agents, the full-service SEC filing agency for public companies, private equity firms, and securities law firms, today announced that the company has partnered with EZOnlineDocuments,...
Feb 22, 2018 12:01 pm UTC| Business
Net sales increase of 11.2% in the quarter reflecting strong double-digit growth in PrintwearFourth quarter GAAP diluted EPS of $0.25 and adjusted diluted EPS of $0.31 Full year 2017 GAAP diluted EPS of $1.61; adjusted...
Norwegian Cruise Line Holdings Reports Financial Results for the Fourth Quarter and Full Year 2017
Feb 22, 2018 12:01 pm UTC| Business
Robust Revenue Growth Drives Record Earnings for Fourth Quarter and Full Year 2017 Strong Full Year 2017 EPS Growth of 19% Company Enters 2018 with Booked Position at All-Time High MIAMI, Feb. 22, 2018 -- Norwegian...
Feb 22, 2018 12:01 pm UTC| Business
LAFAYETTE, La. and LOUISVILLE, Ky., Feb. 22, 2018 -- LHC Group, Inc. (“LHC Group”) (NASDAQ:LHCG) and Almost Family, Inc. (“Almost Family”) (NASDAQ:AFAM) announced today that the waiting period under the...
RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update
Feb 22, 2018 12:01 pm UTC| Business
Key Highlights: Top-line results from the Phase III study with RHB-104 for Crohn’s disease expected in mid-2018Top-line results from the confirmatory Phase III study with TALICIA® for H. pylori infection expected in the...